| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |